company background image
CRON logo

Cronos Group TSX:CRON Stock Report

Last Price

CA$3.45

Market Cap

CA$1.3b

7D

-5.7%

1Y

39.1%

Updated

14 Apr, 2024

Data

Company Financials +

CRON Stock Overview

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany.

CRON fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for CRON from our risk checks.

Cronos Group Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cronos Group
Historical stock prices
Current Share PriceCA$3.45
52 Week HighCA$4.01
52 Week LowCA$2.15
Beta1.12
1 Month Change21.05%
3 Month Change23.66%
1 Year Change39.11%
3 Year Change-66.92%
5 Year Change-83.66%
Change since IPO315.66%

Recent News & Updates

Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce

Apr 01
Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce

Recent updates

Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce

Apr 01
Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Mar 02
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Revenues Tell The Story For Cronos Group Inc. (TSE:CRON)

Feb 02
Revenues Tell The Story For Cronos Group Inc. (TSE:CRON)

Companies Like Cronos Group (TSE:CRON) Are In A Position To Invest In Growth

Nov 09
Companies Like Cronos Group (TSE:CRON) Are In A Position To Invest In Growth

We're Hopeful That Cronos Group (TSE:CRON) Will Use Its Cash Wisely

Jul 17
We're Hopeful That Cronos Group (TSE:CRON) Will Use Its Cash Wisely

Cronos Group Inc.'s (TSE:CRON) Earnings Haven't Escaped The Attention Of Investors

Jun 20
Cronos Group Inc.'s (TSE:CRON) Earnings Haven't Escaped The Attention Of Investors

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Feb 09
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)

Oct 12
A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)

We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate

Sep 10
We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate

Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Aug 12
Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

May 19
We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount?

Jul 29
Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount?

An Intrinsic Calculation For Cronos Group Inc. (TSE:CRON) Suggests It's 29% Undervalued

Apr 08
An Intrinsic Calculation For Cronos Group Inc. (TSE:CRON) Suggests It's 29% Undervalued

Have Insiders Sold Cronos Group Inc. (TSE:CRON) Shares Recently?

Mar 04
Have Insiders Sold Cronos Group Inc. (TSE:CRON) Shares Recently?

What You Need To Know About Cronos Group Inc.'s (TSE:CRON) Investor Composition

Jan 22
What You Need To Know About Cronos Group Inc.'s (TSE:CRON) Investor Composition

Does Cronos Group's (TSE:CRON) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 18
Does Cronos Group's (TSE:CRON) Statutory Profit Adequately Reflect Its Underlying Profit?

Shareholder Returns

CRONCA PharmaceuticalsCA Market
7D-5.7%-8.4%-1.4%
1Y39.1%52.3%4.7%

Return vs Industry: CRON underperformed the Canadian Pharmaceuticals industry which returned 52.3% over the past year.

Return vs Market: CRON exceeded the Canadian Market which returned 4.7% over the past year.

Price Volatility

Is CRON's price volatile compared to industry and market?
CRON volatility
CRON Average Weekly Movement7.4%
Pharmaceuticals Industry Average Movement14.3%
Market Average Movement9.1%
10% most volatile stocks in CA Market18.6%
10% least volatile stocks in CA Market3.1%

Stable Share Price: CRON has not had significant price volatility in the past 3 months.

Volatility Over Time: CRON's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012356Mike Gorensteinwww.thecronosgroup.com

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Cronos Group Inc. Fundamentals Summary

How do Cronos Group's earnings and revenue compare to its market cap?
CRON fundamental statistics
Market capCA$1.32b
Earnings (TTM)-CA$96.23m
Revenue (TTM)CA$120.19m

10.9x

P/S Ratio

-13.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRON income statement (TTM)
RevenueUS$87.24m
Cost of RevenueUS$75.33m
Gross ProfitUS$11.91m
Other ExpensesUS$81.76m
Earnings-US$69.85m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.18
Gross Margin13.65%
Net Profit Margin-80.06%
Debt/Equity Ratio0%

How did CRON perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.